Please login to the form below

KemPharm

This page shows the latest KemPharm news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Pfizer and Teva abuse-resistant painkillers

Last month the same panel also rejected an abuse-deterrent claim for KemPharm's Apadaz (benzhydrocodone hydrochloride and acetaminophen) whilst backing approval of the drug.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Medical Writer: Salary TBC

Senior Medical Writer: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Associate Director: £75, 000-90, 000

Global Business Development Director – Health Education: excellent commission

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Manager / Account Director: Competative

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Account Director, Medical Education: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

NHS regional footprints: What to expect from 2019...
Not another weight-loss ad: Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...